ACS Sensors, Journal Year: 2024, Volume and Issue: 9(9), P. 4328 - 4363
Published: Sept. 6, 2024
Cardiovascular diseases (CVDs) are a predominant global health concern, accounting for over 17.9 million deaths in 2019, representing approximately 32% of all fatalities. In North America and Europe, adults undergo cardiac surgeries annually. Despite the benefits, such pose risks require precise postsurgery monitoring. However, during postdischarge period, where monitoring infrastructures limited, continuous vital signals is hindered. this area, introduction implantable electronics altering medical practices by enabling real-time out-of-hospital physiological biological information postsurgery. The multimodal bioelectronic platforms have capability heart sensing stimulation, both settings. Furthermore, with emergence machine learning algorithms into healthcare devices, next-generation implantables will benefit artificial intelligence (AI) connectivity skin-interfaced to provide more user-specific results. This Review outlines recent advancements bioelectronics their utilization cardiovascular monitoring, highlighting transformative deployment stimulation toward reaching truly personalized compatible Sustainable Development Goal 3.4 WHO 2030 observatory roadmap. also discusses challenges future prospects these devices.
Language: Английский